But one of the rarest muscular disorders is also one of the most concerning. It's called myasthenia gravis and affects only about 37 out of every 100,000 people in the United States. Despite being ...

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

A new study shows that COVID-19 infection significantly increases the risk of exacerbation in patients with myasthenia gravis (MG). Patients with myasthenia gravis (MG) largely expressed negative ...

The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...

The FDA has approved Alexion's Soliris for use in patients with treatment resistant generalised Myasthenia gravis (gMG), making it the first new therapy for the condition in 60 years. The approval ...

The prevalence and incidence rates of myasthenia gravis in the elderly US population have increased from 2006 to 2019.